Kumpulan Info tentang,
UNIVERSITAS SURABAYA
| No | Source Title | CiteScore | Quartile | Publisher | Highest percentile | Citations 2021-24 | Documents 2021-24 |
|---|---|---|---|---|---|---|---|
| 7471 | JACCP Journal of the American College of Clinical Pharmacy | 2.6 | Q2 | John Wiley & Sons | 69.0% 15/47 Pharmacy | 1378 | 522 |
| 7472 | Journal of Medicinal and Chemical Sciences | 2.6 | Q2 | Sami Publishing Company | 68.0% 214/668 General Medicine | 1520 | 593 |
| 7473 | Journal of Microencapsulation | 5.6 | Q2 | Taylor & Francis | 67.0% 68/212 Organic Chemistry | 1049 | 186 |
| 7474 | RSC Medicinal Chemistry | 5.6 | Q2 | Royal Society of Chemistry | 67.0% 68/212 Organic Chemistry | 4591 | 814 |
| 7475 | Current Pharmaceutical Biotechnology | 5.5 | Q2 | Bentham Science Publishers | 65.0% 65/185 Pharmaceutical Science | 3094 | 559 |
| 7476 | Current Nanoscience | 3.7 | Q2 | Bentham Science Publishers | 65.0% 150/433 Medicine (miscellaneous) | 849 | 228 |
| 7477 | Critical Reviews in Therapeutic Drug Carrier Systems | 5.4 | Q2 | Begell House | 64.0% 66/185 Pharmaceutical Science | 380 | 71 |
| 7478 | Bioorganic and Medicinal Chemistry Letters | 5.1 | Q2 | Elsevier | 63.0% 68/185 Pharmaceutical Science | 7634 | 1487 |
| 7479 | Statistics in Biopharmaceutical Research | 2.8 | Q2 | Taylor & Francis | 63.0% 108/293 Statistics and Probability | 604 | 217 |
| 7480 | Open Medicinal Chemistry Journal | 5 | Q2 | Bentham Science Publishers | 62.0% 70/185 Pharmaceutical Science | 105 | 21 |
| 7481 | Drug Development and Industrial Pharmacy | 5 | Q2 | Taylor & Francis | 62.0% 69/185 Pharmaceutical Science | 2048 | 407 |
| 7482 | Fukushima Journal of Medical Sciences | 1.2 | Q2 | Fukushima Society of Medical Science | 62.0% 195/524 Anthropology | 126 | 101 |
| 7483 | Canadian Pharmacists Journal | 2.5 | Q2 | Canadian Pharmacists Association | 62.0% 18/47 Pharmacy | 349 | 139 |
| 7484 | Journal of Asian Natural Products Research | 3.1 | Q2 | Taylor & Francis | 61.0% 44/112 Complementary and Alternative Medicine | 1541 | 497 |
| 7485 | Pharmaceutical Development and Technology | 4.7 | Q2 | Taylor & Francis | 60.0% 73/185 Pharmaceutical Science | 1813 | 385 |
| 7486 | Journal of Advanced Pharmacy Education and Research | 2.4 | Q2 | SPER Publications | 60.0% 19/47 Pharmacy | 818 | 335 |
| 7487 | Journal of Pharmaceutical Innovation | 4.3 | Q2 | Springer Nature | 57.0% 80/185 Pharmaceutical Science | 1898 | 444 |
| 7488 | Biopharmaceutics and Drug Disposition | 4.4 | Q2 | John Wiley & Sons | 57.0% 117/275 Pharmacology (medical) | 505 | 114 |
| 7489 | Turkish Journal of Pharmaceutical Sciences | 4.2 | Q2 | Turkish Pharmacists Association | 56.0% 81/185 Pharmaceutical Science | 1244 | 299 |
| 7490 | Therapeutic Delivery | 4.1 | Q2 | Taylor & Francis | 55.0% 82/185 Pharmaceutical Science | 842 | 203 |
| 7491 | Clinical Pharmacology in Drug Development | 3.8 | Q2 | John Wiley & Sons | 54.0% 84/185 Pharmaceutical Science | 2092 | 551 |
| 7492 | Journal of Medicinal and Pharmaceutical Chemistry Research | 3.4 | Q2 | Sami Publishing Company | 53.0% 87/185 Pharmaceutical Science | 1633 | 485 |
| 7493 | Journal of Aerosol Medicine and Pulmonary Drug Delivery | 3.6 | Q2 | Mary Ann Liebert | 53.0% 86/185 Pharmaceutical Science | 489 | 136 |
| 7494 | Pharmaceutical Nanotechnology | 3.3 | Q2 | Bentham Science Publishers | 52.0% 89/185 Pharmaceutical Science | 422 | 127 |
| 7495 | The Lancet Digital Health | 38.4 | Q1 | Elsevier | 99.0% 1/153 Health Informatics | 11489 | 299 |
| 7496 | npj Digital Medicine | 20.3 | Q1 | Springer Nature | 98.0% 3/153 Health Informatics | 17085 | 842 |
| 7497 | International Journal of Health Policy and Management | 7.1 | Q1 | Kerman University of Medical Sciences | 96.0% 2/41 Leadership and Management | 4318 | 608 |
| 7498 | Clinical eHealth | 11.3 | Q1 | KeAi Communications Co. | 93.0% 30/433 Medicine (miscellaneous) | 771 | 68 |
| 7499 | Neuroscience Informatics | 11.7 | Q1 | Elsevier | 93.0% 11/153 Health Informatics | 1288 | 110 |
| 7500 | JMIR Infodemiology | 6.5 | Q1 | JMIR Publications Inc. | 87.0% 39/320 Health Policy | 886 | 137 |